triamterene has been researched along with Cancer Syndromes, Hereditary in 1 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillotin, D | 1 |
| Austin, P | 1 |
| Begum, R | 1 |
| Freitas, MO | 1 |
| Merve, A | 1 |
| Brend, T | 1 |
| Short, S | 1 |
| Marino, S | 1 |
| Martin, SA | 1 |
1 other study available for triamterene and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; DNA Breaks, Double-Stranded; DNA Mismatch R | 2017 |